Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The rate and costs attributable to intravenous patient-controlled analgesia errors.

Meissner B, Nelson W, Hicks R (R), et al. The rate and costs attributable to intravenous patient-controlled analgesia errors. Hosp Pharm. 2010;44(4):312-324. doi:10.1310/hpj4404-312.

Save
Print
May 24, 2015
Meissner B, Nelson W, Hicks R (R), et al. Hosp Pharm. 2010;44(4):312-324.
View more articles from the same authors.

Medication errors associated with patient-controlled analgesia (PCA) are common and costly, according to this analysis of MEDMARX data. An AHRQ WebM&M commentary discusses a serious adverse drug event in a postoperative patient receiving PCA.

Save
Print
Cite
Citation

Meissner B, Nelson W, Hicks R (R), et al. The rate and costs attributable to intravenous patient-controlled analgesia errors. Hosp Pharm. 2010;44(4):312-324. doi:10.1310/hpj4404-312.